NCT05027061View on ClinicalTrials.gov

A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

CompletedOBSERVATIONAL
Enrollment

11,776

Participants

Timeline

Start Date

April 2, 2021

Primary Completion Date

December 4, 2021

Study Completion Date

December 4, 2021

Conditions
Non-Valvular Atrial Fibrillation (NVAF)
Trial Locations (1)

1070052

Local Institution, Tokyo

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05027061 - A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan | Biotech Hunter | Biotech Hunter